Stifel analysts maintained a Hold rating on ALX Oncology (NASDAQ:ALXO), currently trading at $1.50 with a market cap of $79.1 ...

H.C. Wainwright analysts have reduced the price target for ALX Oncology (NASDAQ:ALXO) shares to $5 from the previous $25 ...

David M. Waterhouse, MD, MPH, and Molly Mendenhall, MBOE, LSSBB, BSN, RN, discuss how the implementation of Lean Six Sigma methodology at Oncology Hematology Care in Cincinnati, Ohio, has transformed ...

Imagine a career in a field you can’t imagine. Dominique Constantini parlayed her commitment to immunology to meeting unmet ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Researchers identified a 15-year shift toward surgical de-escalation in gynecologic oncology, marked by fewer surgical ...

Predictive Oncology Inc (POAI) stock saw a modest uptick, ending the day at $1.48 which represents a slight increase of $0.21 or 16.54% from the prior close of $1.27. The stock opened at $1.58 and ...

The Precision Oncology Showcase is a webinar series sponsored by SOPHiA GENETICS, set to redefine how precision oncology is ...

Some six and a half years since its debut, Servier’s U.S. arm has made good on its oncology growth ambitions while managing to stay true to its patient-centric ethos along the way. | Some six and a ...

A French cohort study confirmed high risks for lymphoma and small bowel cancer in patients with celiac disease but also found elevated risks for pancreatic, esophageal, gastric and colonic cancers ...

Dr. Victoria Forte has been appointed chief of the Division of Hematology/Oncology, Cancer Service Line director, and ...